---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-035700"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2023-10-04T23:59:59+00:00"
generated_at: "2026-06-10T04:50:14.857476+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics discloses PCT patent filing for chemo delivery enhancement system

## Summary
- PCT application entitled 'SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY' submitted.
- Technologies ChemoPrep and ChemoPure aim to increase tumor-site drug delivery and reduce off-target toxicity.
- PCT allows simultaneous patent protection in over 150 countries; related US provisional previously filed.
- Company plans first-in-human studies for Sigyn Therapy; candidate indications include sepsis and pneumonia.
- Reduced chemo dosing may alleviate nationwide drug shortages, per the release.

## SEC filing metadata
- accession: 0001493152-23-035700
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2023-10-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315223035700/0001493152-23-035700-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315223035700/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-035700
- JSON: https://secwatch.observer/filing/0001493152-23-035700.json
- Plain text: https://secwatch.observer/filing/0001493152-23-035700.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.